Prospective Analysis on Survival Outcomes of Nonsmall Cell Lung Cancer Stages over Ⅲb Treated with HangAm-Dan

BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) stages over Ⅲb still remain as an intractable disease. Survival rate of NSCLC stages over Ⅲb could be increased through chemotherapy and radiation, but results are not satisfactory. Oriental medicine herbal formula, HangAm-Dan (HAD) has be...

Descripción completa

Detalles Bibliográficos
Autores principales: JEONG, Tae-Young, PARK, Bong-Ky, LEE, Yeon-Weol, CHO, Chong-Kwan, YOO, Hwa-Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2010
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000501/
https://www.ncbi.nlm.nih.gov/pubmed/21081039
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000501/
https://www.ncbi.nlm.nih.gov/pubmed/21081039
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.03

Ejemplares similares